These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 20331708)

  • 1. The pathophysiology of tuberous sclerosis complex.
    Crino PB
    Epilepsia; 2010 Feb; 51 Suppl 1():27-9. PubMed ID: 20331708
    [No Abstract]   [Full Text] [Related]  

  • 2. CDKs as therapeutic targets for the human genetic disease tuberous sclerosis?
    Rosner M; Dolznig H; Fuchs C; Siegel N; Valli A; Hengstschläger M
    Eur J Clin Invest; 2009 Dec; 39(12):1033-5. PubMed ID: 19744185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomedicine. A new view on--and hope for--an old disease.
    Cahoon L
    Science; 2009 Jan; 323(5911):203-5. PubMed ID: 19131605
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular activity of sirolimus and its possible application in tuberous sclerosis treatment.
    Jozwiak J; Jozwiak S; Oldak M
    Med Res Rev; 2006 Mar; 26(2):160-80. PubMed ID: 16329102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberous sclerosis: genes, brain, and behaviour.
    Curatolo P
    Dev Med Child Neurol; 2006 Jun; 48(6):404. PubMed ID: 16700926
    [No Abstract]   [Full Text] [Related]  

  • 6. Recent advances in neurobiology of Tuberous Sclerosis Complex.
    Napolioni V; Moavero R; Curatolo P
    Brain Dev; 2009 Feb; 31(2):104-13. PubMed ID: 19028034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tuberous sclerosis].
    Metsähonkala L; Valanne L; Anttonen AK
    Duodecim; 2013; 129(17):1779-87. PubMed ID: 24159711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapamycin as a therapy of choice after renal transplantation in a patient with tuberous sclerosis complex.
    Tarasewicz A; Debska-Slizień A; Konopa J; Zdrojewski Z; Rutkowski B
    Transplant Proc; 2009 Nov; 41(9):3677-82. PubMed ID: 19917366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotype-phenotype correlations in tuberous sclerosis: who and how to treat.
    Goh S; Weiss WA
    Ann Neurol; 2006 Nov; 60(5):505-507. PubMed ID: 17120247
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of sirolimus in treating tuberous sclerosis and lymphangioleiomyomatosis.
    Paul E; Thiele E
    N Engl J Med; 2008 Jan; 358(2):190-2. PubMed ID: 18184966
    [No Abstract]   [Full Text] [Related]  

  • 11. mTOR in tuberous sclerosis and other neurological disorders.
    Franz DN
    Epilepsia; 2007 Aug; 48(8):1630-1; author reply 1632-4. PubMed ID: 17692052
    [No Abstract]   [Full Text] [Related]  

  • 12. Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype--phenotype correlations and comparison of diagnostic DNA techniques in Tuberous Sclerosis Complex.
    Sancak O; Nellist M; Goedbloed M; Elfferich P; Wouters C; Maat-Kievit A; Zonnenberg B; Verhoef S; Halley D; van den Ouweland A
    Eur J Hum Genet; 2005 Jun; 13(6):731-41. PubMed ID: 15798777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirolimus therapy for fibromatosis and multifocal renal cell carcinoma in a child with tuberous sclerosis complex.
    Pressey JG; Wright JM; Geller JI; Joseph DB; Pressey CS; Kelly DR
    Pediatr Blood Cancer; 2010 Jul; 54(7):1035-7. PubMed ID: 20108343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diverse clinical manifestations of tuberous sclerosis complex: a review.
    Rosser T; Panigrahy A; McClintock W
    Semin Pediatr Neurol; 2006 Mar; 13(1):27-36. PubMed ID: 16818173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberous sclerosis complex: clinical features, diagnosis, and prevalence within Northern Ireland.
    Devlin LA; Shepherd CH; Crawford H; Morrison PJ
    Dev Med Child Neurol; 2006 Jun; 48(6):495-9. PubMed ID: 16700943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapamycin and tuberous sclerosis complex: from Easter Island to epilepsy.
    Crino PB
    Ann Neurol; 2008 Apr; 63(4):415-7. PubMed ID: 18360828
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyst-like tubers are associated with TSC2 and epilepsy in tuberous sclerosis complex.
    Chu-Shore CJ; Major P; Montenegro M; Thiele E
    Neurology; 2009 Mar; 72(13):1165-9. PubMed ID: 19332694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overlapping neurologic and cognitive phenotypes in patients with TSC1 or TSC2 mutations.
    Jansen FE; Braams O; Vincken KL; Algra A; Anbeek P; Jennekens-Schinkel A; Halley D; Zonnenberg BA; van den Ouweland A; van Huffelen AC; van Nieuwenhuizen O; Nellist M
    Neurology; 2008 Mar; 70(12):908-15. PubMed ID: 18032745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Markers of cellular proliferation are expressed in cortical tubers.
    Lee A; Maldonado M; Baybis M; Walsh CA; Scheithauer B; Yeung R; Parent J; Weiner HL; Crino PB
    Ann Neurol; 2003 May; 53(5):668-73. PubMed ID: 12731003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and genotype studies of cardiac tumors in 154 patients with tuberous sclerosis complex.
    Jóźwiak S; Kotulska K; Kasprzyk-Obara J; Domańska-Pakieła D; Tomyn-Drabik M; Roberts P; Kwiatkowski D
    Pediatrics; 2006 Oct; 118(4):e1146-51. PubMed ID: 16940165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.